aluates Reports

$ 0.0

Automative

Global Osimertinib Mesylate Tablets Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-20P18263

BUY CHAPTERS

Global Osimertinib Mesylate Tablets Market Research Report 2024

Code: QYRE-Auto-20P18263

Report

August 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Zydus

Drug International

Beacon

General Pharmaceuticals

Wanbang Biopharmaceuticals

Pharmacil

Osimertinib Mesylate Tablets Market

Osimertinib mesylate tablets are a medication used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations.These tablets are designed to inhibit the activity of the mutated EGFR, thereby slowing down or stopping cancer cell growth,which are often prescribed for patients with advanced or metastatic NSCLC who have developed resistance to other EGFR-targeted therapies.

The global Osimertinib Mesylate Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Osimertinib Mesylate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Osimertinib Mesylate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Osimertinib Mesylate Tablets include AstraZeneca, Zydus, Drug International, Beacon, General Pharmaceuticals, Pharmacil, Wanbang Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Osimertinib Mesylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osimertinib Mesylate Tablets.

The Osimertinib Mesylate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Osimertinib Mesylate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Osimertinib Mesylate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Osimertinib Mesylate Tablets Market Report

Report Metric	Details
Report Name	Osimertinib Mesylate Tablets Market
Segment by Type	Original Drug Generic Drug
Segment by Application	Hospital and Clinic Retail Pharmacies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca, Zydus, Drug International, Beacon, General Pharmaceuticals, Pharmacil, Wanbang Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Osimertinib Mesylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Osimertinib Mesylate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Osimertinib Mesylate Tablets Market report?

Ans: The main players in the Osimertinib Mesylate Tablets Market are AstraZeneca, Zydus, Drug International, Beacon, General Pharmaceuticals, Pharmacil, Wanbang Biopharmaceuticals

What are the Application segmentation covered in the Osimertinib Mesylate Tablets Market report?

Ans: The Applications covered in the Osimertinib Mesylate Tablets Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Osimertinib Mesylate Tablets Market report?

Ans: The Types covered in the Osimertinib Mesylate Tablets Market report are Original Drug, Generic Drug

Recommended Reports

Lung Cancer Drugs

Cancer Therapeutics

EGFR and Targeted

1 Osimertinib Mesylate Tablets Market Overview

1.1 Product Definition

1.2 Osimertinib Mesylate Tablets by Type

1.2.1 Global Osimertinib Mesylate Tablets Market Value Comparison by Type (2024-2030)

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Osimertinib Mesylate Tablets by Application

1.3.1 Global Osimertinib Mesylate Tablets Market Value by Application (2024-2030)

1.3.2 Hospital and Clinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Global Osimertinib Mesylate Tablets Market Size Estimates and Forecasts

1.4.1 Global Osimertinib Mesylate Tablets Revenue 2019-2030

1.4.2 Global Osimertinib Mesylate Tablets Sales 2019-2030

1.4.3 Global Osimertinib Mesylate Tablets Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Osimertinib Mesylate Tablets Market Competition by Manufacturers

2.1 Global Osimertinib Mesylate Tablets Sales Market Share by Manufacturers (2019-2024)

2.2 Global Osimertinib Mesylate Tablets Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Osimertinib Mesylate Tablets Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Osimertinib Mesylate Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Osimertinib Mesylate Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Osimertinib Mesylate Tablets, Product Type & Application

2.7 Global Key Manufacturers of Osimertinib Mesylate Tablets, Date of Enter into This Industry

2.8 Global Osimertinib Mesylate Tablets Market Competitive Situation and Trends

2.8.1 Global Osimertinib Mesylate Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Osimertinib Mesylate Tablets Players Market Share by Revenue

2.8.3 Global Osimertinib Mesylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Osimertinib Mesylate Tablets Market Scenario by Region

3.1 Global Osimertinib Mesylate Tablets Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Osimertinib Mesylate Tablets Sales by Region: 2019-2030

3.2.1 Global Osimertinib Mesylate Tablets Sales by Region: 2019-2024

3.2.2 Global Osimertinib Mesylate Tablets Sales by Region: 2025-2030

3.3 Global Osimertinib Mesylate Tablets Revenue by Region: 2019-2030

3.3.1 Global Osimertinib Mesylate Tablets Revenue by Region: 2019-2024

3.3.2 Global Osimertinib Mesylate Tablets Revenue by Region: 2025-2030

3.4 North America Osimertinib Mesylate Tablets Market Facts & Figures by Country

3.4.1 North America Osimertinib Mesylate Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Osimertinib Mesylate Tablets Sales by Country (2019-2030)

3.4.3 North America Osimertinib Mesylate Tablets Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Osimertinib Mesylate Tablets Market Facts & Figures by Country

3.5.1 Europe Osimertinib Mesylate Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Osimertinib Mesylate Tablets Sales by Country (2019-2030)

3.5.3 Europe Osimertinib Mesylate Tablets Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Osimertinib Mesylate Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Osimertinib Mesylate Tablets Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Osimertinib Mesylate Tablets Sales by Region (2019-2030)

3.6.3 Asia Pacific Osimertinib Mesylate Tablets Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Osimertinib Mesylate Tablets Market Facts & Figures by Country

3.7.1 Latin America Osimertinib Mesylate Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Osimertinib Mesylate Tablets Sales by Country (2019-2030)

3.7.3 Latin America Osimertinib Mesylate Tablets Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Osimertinib Mesylate Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Osimertinib Mesylate Tablets Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2019-2030)

3.8.3 Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Osimertinib Mesylate Tablets Sales by Type (2019-2030)

4.1.1 Global Osimertinib Mesylate Tablets Sales by Type (2019-2024)

4.1.2 Global Osimertinib Mesylate Tablets Sales by Type (2025-2030)

4.1.3 Global Osimertinib Mesylate Tablets Sales Market Share by Type (2019-2030)

4.2 Global Osimertinib Mesylate Tablets Revenue by Type (2019-2030)

4.2.1 Global Osimertinib Mesylate Tablets Revenue by Type (2019-2024)

4.2.2 Global Osimertinib Mesylate Tablets Revenue by Type (2025-2030)

4.2.3 Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2019-2030)

4.3 Global Osimertinib Mesylate Tablets Price by Type (2019-2030)

5 Segment by Application

5.1 Global Osimertinib Mesylate Tablets Sales by Application (2019-2030)

5.1.1 Global Osimertinib Mesylate Tablets Sales by Application (2019-2024)

5.1.2 Global Osimertinib Mesylate Tablets Sales by Application (2025-2030)

5.1.3 Global Osimertinib Mesylate Tablets Sales Market Share by Application (2019-2030)

5.2 Global Osimertinib Mesylate Tablets Revenue by Application (2019-2030)

5.2.1 Global Osimertinib Mesylate Tablets Revenue by Application (2019-2024)

5.2.2 Global Osimertinib Mesylate Tablets Revenue by Application (2025-2030)

5.2.3 Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2019-2030)

5.3 Global Osimertinib Mesylate Tablets Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Company Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AstraZeneca Osimertinib Mesylate Tablets Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Zydus

6.2.1 Zydus Company Information

6.2.2 Zydus Description and Business Overview

6.2.3 Zydus Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Zydus Osimertinib Mesylate Tablets Product Portfolio

6.2.5 Zydus Recent Developments/Updates

6.3 Drug International

6.3.1 Drug International Company Information

6.3.2 Drug International Description and Business Overview

6.3.3 Drug International Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Drug International Osimertinib Mesylate Tablets Product Portfolio

6.3.5 Drug International Recent Developments/Updates

6.4 Beacon

6.4.1 Beacon Company Information

6.4.2 Beacon Description and Business Overview

6.4.3 Beacon Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Beacon Osimertinib Mesylate Tablets Product Portfolio

6.4.5 Beacon Recent Developments/Updates

6.5 General Pharmaceuticals

6.5.1 General Pharmaceuticals Company Information

6.5.2 General Pharmaceuticals Description and Business Overview

6.5.3 General Pharmaceuticals Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2019-2024)

6.5.4 General Pharmaceuticals Osimertinib Mesylate Tablets Product Portfolio

6.5.5 General Pharmaceuticals Recent Developments/Updates

6.6 Pharmacil

6.6.1 Pharmacil Company Information

6.6.2 Pharmacil Description and Business Overview

6.6.3 Pharmacil Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pharmacil Osimertinib Mesylate Tablets Product Portfolio

6.6.5 Pharmacil Recent Developments/Updates

6.7 Wanbang Biopharmaceuticals

6.7.1 Wanbang Biopharmaceuticals Company Information

6.7.2 Wanbang Biopharmaceuticals Description and Business Overview

6.7.3 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product Portfolio

6.7.5 Wanbang Biopharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Osimertinib Mesylate Tablets Industry Chain Analysis

7.2 Osimertinib Mesylate Tablets Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Osimertinib Mesylate Tablets Production Mode & Process

7.4 Osimertinib Mesylate Tablets Sales and Marketing

7.4.1 Osimertinib Mesylate Tablets Sales Channels

7.4.2 Osimertinib Mesylate Tablets Distributors

7.5 Osimertinib Mesylate Tablets Customers

8 Osimertinib Mesylate Tablets Market Dynamics

8.1 Osimertinib Mesylate Tablets Industry Trends

8.2 Osimertinib Mesylate Tablets Market Drivers

8.3 Osimertinib Mesylate Tablets Market Challenges

8.4 Osimertinib Mesylate Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Zydus

Drug International

Beacon

General Pharmaceuticals

Wanbang Biopharmaceuticals

Pharmacil

List of Tables

Table 1. Global Osimertinib Mesylate Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Osimertinib Mesylate Tablets Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Osimertinib Mesylate Tablets Market Competitive Situation by Manufacturers in 2023

Table 4. Global Osimertinib Mesylate Tablets Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Osimertinib Mesylate Tablets Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Osimertinib Mesylate Tablets Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Osimertinib Mesylate Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Osimertinib Mesylate Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Osimertinib Mesylate Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Osimertinib Mesylate Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Osimertinib Mesylate Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Osimertinib Mesylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osimertinib Mesylate Tablets as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Osimertinib Mesylate Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Osimertinib Mesylate Tablets Sales by Region (2019-2024) & (K Units)

Table 18. Global Osimertinib Mesylate Tablets Sales Market Share by Region (2019-2024)

Table 19. Global Osimertinib Mesylate Tablets Sales by Region (2025-2030) & (K Units)

Table 20. Global Osimertinib Mesylate Tablets Sales Market Share by Region (2025-2030)

Table 21. Global Osimertinib Mesylate Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Osimertinib Mesylate Tablets Revenue Market Share by Region (2019-2024)

Table 23. Global Osimertinib Mesylate Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Osimertinib Mesylate Tablets Revenue Market Share by Region (2025-2030)

Table 25. North America Osimertinib Mesylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Osimertinib Mesylate Tablets Sales by Country (2019-2024) & (K Units)

Table 27. North America Osimertinib Mesylate Tablets Sales by Country (2025-2030) & (K Units)

Table 28. North America Osimertinib Mesylate Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Osimertinib Mesylate Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Osimertinib Mesylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Osimertinib Mesylate Tablets Sales by Country (2019-2024) & (K Units)

Table 32. Europe Osimertinib Mesylate Tablets Sales by Country (2025-2030) & (K Units)

Table 33. Europe Osimertinib Mesylate Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Osimertinib Mesylate Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Osimertinib Mesylate Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Osimertinib Mesylate Tablets Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Osimertinib Mesylate Tablets Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Osimertinib Mesylate Tablets Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Osimertinib Mesylate Tablets Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Osimertinib Mesylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Osimertinib Mesylate Tablets Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Osimertinib Mesylate Tablets Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Osimertinib Mesylate Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Osimertinib Mesylate Tablets Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Osimertinib Mesylate Tablets Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Osimertinib Mesylate Tablets Sales (K Units) by Type (2019-2024)

Table 51. Global Osimertinib Mesylate Tablets Sales (K Units) by Type (2025-2030)

Table 52. Global Osimertinib Mesylate Tablets Sales Market Share by Type (2019-2024)

Table 53. Global Osimertinib Mesylate Tablets Sales Market Share by Type (2025-2030)

Table 54. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2019-2024)

Table 57. Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2025-2030)

Table 58. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Type (2019-2024)

Table 59. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Type (2025-2030)

Table 60. Global Osimertinib Mesylate Tablets Sales (K Units) by Application (2019-2024)

Table 61. Global Osimertinib Mesylate Tablets Sales (K Units) by Application (2025-2030)

Table 62. Global Osimertinib Mesylate Tablets Sales Market Share by Application (2019-2024)

Table 63. Global Osimertinib Mesylate Tablets Sales Market Share by Application (2025-2030)

Table 64. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Osimertinib Mesylate Tablets Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2019-2024)

Table 67. Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2025-2030)

Table 68. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Application (2019-2024)

Table 69. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Application (2025-2030)

Table 70. AstraZeneca Company Information

Table 71. AstraZeneca Description and Business Overview

Table 72. AstraZeneca Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. AstraZeneca Osimertinib Mesylate Tablets Product

Table 74. AstraZeneca Recent Developments/Updates

Table 75. Zydus Company Information

Table 76. Zydus Description and Business Overview

Table 77. Zydus Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Zydus Osimertinib Mesylate Tablets Product

Table 79. Zydus Recent Developments/Updates

Table 80. Drug International Company Information

Table 81. Drug International Description and Business Overview

Table 82. Drug International Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Drug International Osimertinib Mesylate Tablets Product

Table 84. Drug International Recent Developments/Updates

Table 85. Beacon Company Information

Table 86. Beacon Description and Business Overview

Table 87. Beacon Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Beacon Osimertinib Mesylate Tablets Product

Table 89. Beacon Recent Developments/Updates

Table 90. General Pharmaceuticals Company Information

Table 91. General Pharmaceuticals Description and Business Overview

Table 92. General Pharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. General Pharmaceuticals Osimertinib Mesylate Tablets Product

Table 94. General Pharmaceuticals Recent Developments/Updates

Table 95. Pharmacil Company Information

Table 96. Pharmacil Description and Business Overview

Table 97. Pharmacil Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Pharmacil Osimertinib Mesylate Tablets Product

Table 99. Pharmacil Recent Developments/Updates

Table 100. Wanbang Biopharmaceuticals Company Information

Table 101. Wanbang Biopharmaceuticals Description and Business Overview

Table 102. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product

Table 104. Wanbang Biopharmaceuticals Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Osimertinib Mesylate Tablets Distributors List

Table 108. Osimertinib Mesylate Tablets Customers List

Table 109. Osimertinib Mesylate Tablets Market Trends

Table 110. Osimertinib Mesylate Tablets Market Drivers

Table 111. Osimertinib Mesylate Tablets Market Challenges

Table 112. Osimertinib Mesylate Tablets Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Osimertinib Mesylate Tablets

Figure 2. Global Osimertinib Mesylate Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Osimertinib Mesylate Tablets Market Share by Type: 2023 & 2030

Figure 4. Original Drug Product Picture

Figure 5. Generic Drug Product Picture

Figure 6. Global Osimertinib Mesylate Tablets Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Osimertinib Mesylate Tablets Market Share by Application: 2023 & 2030

Figure 8. Hospital and Clinic

Figure 9. Retail Pharmacies

Figure 10. Other

Figure 11. Global Osimertinib Mesylate Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Osimertinib Mesylate Tablets Market Size (2019-2030) & (US$ Million)

Figure 13. Global Osimertinib Mesylate Tablets Sales (2019-2030) & (K Units)

Figure 14. Global Osimertinib Mesylate Tablets Average Price (US$/Unit) & (2019-2030)

Figure 15. Osimertinib Mesylate Tablets Report Years Considered

Figure 16. Osimertinib Mesylate Tablets Sales Share by Manufacturers in 2023

Figure 17. Global Osimertinib Mesylate Tablets Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Osimertinib Mesylate Tablets Players: Market Share by Revenue in Osimertinib Mesylate Tablets in 2023

Figure 19. Osimertinib Mesylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Osimertinib Mesylate Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Osimertinib Mesylate Tablets Sales Market Share by Country (2019-2030)

Figure 22. North America Osimertinib Mesylate Tablets Revenue Market Share by Country (2019-2030)

Figure 23. United States Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Osimertinib Mesylate Tablets Sales Market Share by Country (2019-2030)

Figure 26. Europe Osimertinib Mesylate Tablets Revenue Market Share by Country (2019-2030)

Figure 27. Germany Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Osimertinib Mesylate Tablets Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Osimertinib Mesylate Tablets Revenue Market Share by Region (2019-2030)

Figure 34. China Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Osimertinib Mesylate Tablets Sales Market Share by Country (2019-2030)

Figure 42. Mexico Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Osimertinib Mesylate Tablets Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Osimertinib Mesylate Tablets Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Osimertinib Mesylate Tablets by Type (2019-2030)

Figure 52. Global Revenue Market Share of Osimertinib Mesylate Tablets by Type (2019-2030)

Figure 53. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Osimertinib Mesylate Tablets by Application (2019-2030)

Figure 55. Global Revenue Market Share of Osimertinib Mesylate Tablets by Application (2019-2030)

Figure 56. Global Osimertinib Mesylate Tablets Price (US$/Unit) by Application (2019-2030)

Figure 57. Osimertinib Mesylate Tablets Value Chain

Figure 58. Osimertinib Mesylate Tablets Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Osimertinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sorafenib Tosylate Tablets Market Research Report 2024

Global Osimertinib Market Research Report 2024

Global Cabozantinib Tablets Market Research Report 2024

Erlotinib Hydrochloride Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ceritinib Capsules Market Research Report 2024

Global Axitinib Tablets Market Research Report 2024

Global Savolitinib Tablets Market Research Report 2024

Global Ceritinib API Market Research Report 2024

Global Ponatinib Tablets Market Research Report 2024

Imatinib Mesylate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Regorafenib Drugs Market Research Report 2024

Global Afatinib API Market Research Report 2024

Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Crizotinib Drugs Market Research Report 2024

Global EGFR TKI Market Research Report 2024

Global Gilteritinib API Market Research Report 2024

Global Brigatinib Tablet Market Insights Forecast to 2030

Global Sunitinib Generics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions